Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure of Cash Flow Information

v3.20.1
Supplemental Disclosure of Cash Flow Information
12 Months Ended
Dec. 31, 2019
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information

Note 19 – Supplemental Disclosure of Cash Flow Information

 

    Year Ended December 31,  
    2019     2018  
Cash paid for interest   $ -     $ 313,918  
Cash paid for income taxes   $ 45,000     $ 23,362  
                 
Acquisitions of Hospitals and Medical Centers:                
Cash   $ -     $ 375  
Inventory     317,427       450,682  
Prepaid and other current assets     -       310,385  
Property and equipments     500,000       7,129,484  
Intangible assets     250,000       504,806  
Accrued expenses     158,890       (193,966 )
                 
Non-cash investing and financing activities:                
Common stock issued for conversion of Series I-2 Preferred Stock     1,268,972       1,513,105  
Exchange of debentures for Series I-2 Preferred Stock     -       1,420  
Series J Preferred Stock issued in exchange for notes payable and accrued expenses     -       250,000  
Issuance of Series K Preferred Stock     2,500       -  
Exchange of Series J Preferred Stock for Series K Preferred Stock     (2,500 )     -  
Common stock issued in cashless exercise of warrants     11,962       4,619,150  
Conversion of Series H Preferred Stock     -       50,000  
Debentures converted into common stock     -       8,128,044  
Original issue discounts of debentures and notes payable     400,000       2,160,000  
Deemed dividend for trigger of down round provision feature     123,861,587       231,843,826